Tag:
Warburg Pincus
Latest Headlines
Latest Headlines
Rib-X's antibiotic pipeline garners $20M in funding
With Warburg Pincus leading the way, Rib-X has landed $20 million in venture capital funding to support development of its antibiotic pipeline. Rib-X's main objective is to begin a Phase IIb study
Inspire abandons nasal spray after drug flunks trial
Disappointed by lackluster data, Inspire Pharmaceuticals has abandoned development of its epinastine nasal spray for the treatment of seasonal allergic rhinitis. Subjects treated with the nasal
ALSO NOTED: Neurochem pursues new Kiacta trial; Teva drug fails ALS trial; Columbus tapped as promising new life sciences hub;
> Neurochem is forging ahead with plans to launch a new late-stage trial for Kiacta in a renewed bid for regulatory approval. Regulators had declined to approve the amyloidosis therapy, saying
ALSO NOTED: Novartis plots $700M biotech plant; Genzyme wins marketing approval; Glenmark, Forest to pursue Phase II; and much
> Novartis will plow $700 million into a new cell-culturing facility in Singapore. The plant will boost the drug maker's capacity for biotech drugs, delivering products for commercial distribution
